We are live on
!
Find out more
ARRY
Array Biopharma Inc
ARRY
ARRY
Delisted
ARRY was delisted on the 29th of July, 2019.
235 hedge funds and large institutions have $3.22B invested in Array Biopharma Inc in 2018 Q1 according to their latest regulatory filings, with 66 funds opening new positions, 83 increasing their positions, 62 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
230% more first-time investments, than exits
New positions opened: 66 | Existing positions closed: 20
46% more call options, than puts
Call options by funds: $27.3M | Put options by funds: $18.7M
34% more repeat investments, than reductions
Existing positions increased: 83 | Existing positions reduced: 62
26% more capital invested
Capital invested by funds: $2.56B → $3.22B (+$660M)
23% more funds holding
Funds holding: 191 → 235 (+44)
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
Holders
235
Holders Change
+44
Holders Change %
+23.04%
% of All Funds
5.39%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.16%
New
66
Increased
83
Reduced
62
Closed
20
Calls
$27.3M
Puts
$18.7M
Net Calls
+$8.62M
Net Calls Change
-$12.9M
Top Buyers
Top Sellers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$84.3M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
-$58M |
| 3 |
ACA
Avoro Capital Advisors
New York
|
-$56.8M |
| 4 |
O
OrbiMed
New York
|
-$43.6M |
| 5 |
Morgan Stanley
New York
|
-$33.7M |
